WallStreetZenWallStreetZen

NASDAQ: SAGE
Sage Therapeutics Inc Stock Ownership - Who owns Sage Therapeutics?

Insider buying vs selling

Have Sage Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Kimi IguchiCFO Treasurer2024-01-021,642$1.36
$2.23kBuy
Jeffrey M. JonasDirector2023-11-283,935$19.27
$75.83kSell
Anne Marie CookSVP GC Secretary2023-11-281,174$19.27
$22.62kSell
Kimi IguchiCFO Treasurer2023-11-28943$19.27
$18.17kSell
Elizabeth BarrettDirector2023-08-092,000$18.64
$37.28kBuy
Elizabeth BarrettDirector2023-05-091,000$50.50
$50.50kBuy
Kimi IguchiCFO Treasurer2023-03-153,000$1.36
$4.08kBuy

1 of 1

SAGE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SAGE insiders and whales buy or sell their stock.

SAGE Shareholders

What type of owners hold Sage Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Steven M. Paul12.37%7,432,477$162.47MInsider
Biogen Inc10.38%6,241,473$136.44MInsider
Wellington Management Group LLP10.09%6,061,996$132.52MInstitution
Fmr LLC9.12%5,482,477$119.85MInstitution
Robert Nelsen9.12%5,482,038$119.84MInsider
Vanguard Group Inc8.85%5,319,360$116.28MInstitution
Rtw Investments LP8.65%5,197,019$113.61MInstitution
Blackrock Inc7.76%4,663,900$101.95MInstitution
State Street Corp6.52%3,918,222$85.65MInstitution
Bellevue Group Ag5.85%3,513,351$76.80MInstitution

1 of 3

SAGE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SAGE71.61%28.39%Net BuyingNet Buying
ADMA74.12%25.24%Net SellingNet Selling
AMLX52.69%47.31%Net SellingNet Buying
VERV62.25%37.75%Net Buying
ETNB85.94%14.06%Net BuyingNet Selling

Sage Therapeutics Stock Ownership FAQ

Who owns Sage Therapeutics?

Sage Therapeutics (NASDAQ: SAGE) is owned by 93.30% institutional shareholders, 36.98% Sage Therapeutics insiders, and 0.00% retail investors. Steven M. Paul is the largest individual Sage Therapeutics shareholder, owning 7.43M shares representing 12.37% of the company. Steven M. Paul's Sage Therapeutics shares are currently valued at $161.81M.

If you're new to stock investing, here's how to buy Sage Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.